Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination

Ellen S. Vitetta, Marvin J. Stone, James A. Richardson, Alex W. Tong, Bing Qing Zhang, Yi Wu Huang, Disseminated Growth of a Human Multiple Myeloma Cell Line in Mice with Severe Combined Immunodeficiency Disease Cancer Research. ,vol. 53, pp. 1392- 1396 ,(1993)

V Munugalavadla, S Mariathasan, D Slaga, C Du, L Berry, G Del Rosario, Y Yan, M Boe, L Sun, L S Friedman, M Chesi, P Leif Bergsagel, A Ebens, The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multiple myeloma Oncogene. ,vol. 33, pp. 316- 325 ,(2014) , 10.1038/ONC.2012.594

Kevin D. Courtney, Ryan B. Corcoran, Jeffrey A. Engelman, The PI3K Pathway As Drug Target in Human Cancer Journal of Clinical Oncology. ,vol. 28, pp. 1075- 1083 ,(2010) , 10.1200/JCO.2009.25.3641

S. Kang, A. Denley, B. Vanhaesebroeck, P. K. Vogt, Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 1289- 1294 ,(2006) , 10.1073/PNAS.0510772103

L Zhao, P K Vogt, Class I PI3K in oncogenic cellular transformation. Oncogene. ,vol. 27, pp. 5486- 5496 ,(2008) , 10.1038/ONC.2008.244

Jordi Rodon, Rodrigo Dienstmann, Violeta Serra, Josep Tabernero, None, Development of PI3K inhibitors: lessons learned from early clinical trials Nature Reviews Clinical Oncology. ,vol. 10, pp. 143- 153 ,(2013) , 10.1038/NRCLINONC.2013.10

Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F Berger, John E Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané-Valbuena, Felipa A Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H Engels, Jill Cheng, Guoying K Yu, Jianjun Yu, Peter Aspesi, Melanie De Silva, Kalpana Jagtap, Michael D Jones, Li Wang, Charles Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C Onofrio, Ted Liefeld, Laura MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P Mesirov, Stacey B Gabriel, Gad Getz, Kristin Ardlie, Vivien Chan, Vic E Myer, Barbara L Weber, Jeff Porter, Markus Warmuth, Peter Finan, Jennifer L Harris, Matthew Meyerson, Todd R Golub, Michael P Morrissey, William R Sellers, Robert Schlegel, Levi A Garraway, None, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature. ,vol. 483, pp. 603- 607 ,(2012) , 10.1038/NATURE11003

Anuj Mahindra, Teru Hideshima, Kenneth C. Anderson, Multiple myeloma: biology of the disease Blood Reviews. ,vol. 24, pp. S5- S11 ,(2010) , 10.1016/S0268-960X(10)70003-5

Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, Giulia Perrone, Naoya Miura, Hiroshi Yasui, Yutaka Okawa, Tanyel Kiziltepe, Loredana Santo, Sonia Vallet, Diana Cristea, Elisabetta Calabrese, Gullu Gorgun, Noopur S Raje, Paul Richardson, Nikhil C Munshi, Brian J Lannutti, Kamal D Puri, Neill A Giese, Kenneth C Anderson, None, PI3K/p110δ is a novel therapeutic target in multiple myeloma Blood. ,vol. 116, pp. 1460- 1468 ,(2010) , 10.1182/BLOOD-2009-06-222943

Bart Vanhaesebroeck, Julie Guillermet-Guibert, Mariona Graupera, Benoit Bilanges, The emerging mechanisms of isoform-specific PI3K signalling Nature Reviews Molecular Cell Biology. ,vol. 11, pp. 329- 341 ,(2010) , 10.1038/NRM2882